Colin Walsh, Director, on August 05, 2026, executed a purchase for 585,000 shares in Attovia Therapeutics (ATTO) for $10,285,000. Following the Form 4 filing with the SEC, Walsh has control over a total of 3,020,632 common shares of the company, with 3,020,632 controlled indirectly.
SEC Filing:
Philip B Hawkins, President and CEO, on August 11, 2026, sold 4,435 shares in McGrath RentCorp (MGRC) for $536,256. Following the Form 4 filing with the SEC, Hawkins has control over a total of 13,371 common shares of the company, with 13,371 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/752714/000140324626000003/xslF345X05/primary_doc.xml
Aldo John Pagliari, Senior Vice President, Finance & CFO, on August 13, 2026, sold 5,531 shares in Snap-on (SNA) for $2,235,898. Following the Form 4 filing with the SEC, Pagliari has control over a total of 120,644 common shares of the company, with 120,644 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/91440/000009144026000156/xslF345X05/form4.xml
Thomas M Siebel, 10% Owner, Director, CEO, and Chairman of the Board, on August 11, 2026, sold 453,314 shares in C3.ai (AI) for $4,764,330. Following the Form 4 filing with the SEC, Siebel has control over a total of 9,278,869 Class A common shares of the company, with 722,362 shares held directly and 8,556,507 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1577526/000157752626000098/xslF345X05/wk-form4_1786656439.xml